Caribbean

Resilience System


Paxlovid fails to improve long COVID symptoms in small study

Primary tabs

Paxlovid fails to improve long COVID symptoms in small study

...

The findings are part of the STOP-PASC trial, and the study was conducted at Stanford University from November 2022 to September 2023. All enrollees reported at least 3 months of postacute sequelae of SARS-CoV-2 infection (PASC) symptoms.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 0.392 seconds.